Clinical trial
Effects on Incidence of Cardiovascular Events of the Addition of Pioglitazone as Compared With a Sulphonylurea in Type 2 Diabetic Patients Inadequately Controlled With Metformin.
NCT00700856 is registered in ClinicalTrials.gov with Italian Society of Diabetology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects on Incidence of Cardiovascular Events of the Addition of Pioglitazone as Compared With a Sulphonylurea in Type 2 Diabetic Patients Inadequately Controlled With Metformin.
- Lead sponsor
- Italian Society of Diabetology
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 30, 2008
- Completion date
- December 31, 2018
- Enrollment
- 3,371 (estimated)
- Sites
- 61
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease, type 2 diabetes mellitus